Literature DB >> 2021384

Post-ischemic release of nucleosides and oxypurines in isolated rat hearts. Possible involvement of ventricular fibrillation.

W Bernauer1.   

Abstract

In isolated perfused rat hearts global ischemia for 2, 5, and 15 min was produced. Depending on the duration of the ischemia, postischemic reperfusion led to the release of adenosine and its catabolites, and to more or less severe ventricular tachyarrhythmias. When ventricular fibrillation occurred, a highly significant increase in the purine release was observed compared with non-fibrillating hearts. Prevention of fibrillation by antiarrhythmic drugs decreased the purine release in a highly significant way. After only 2 min of ischemia, reperfusion did not lead to ventricular fibrillation. Electrical induction of fibrillation during the reperfusion in these hearts provoked the release of very high amounts of the purine compounds. A similar effect of electrically-induced fibrillation was also obtained in hearts without a previous ischemic period. The findings suggest that ventricular fibrillation is able to induce the release of purine derivatives from the heart.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021384     DOI: 10.1007/bf02193866

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  23 in total

1.  Inhibition of slow action potentials of guinea pig atrial muscle by adenosine: a possible effect on Ca2+ influx.

Authors:  J Schrader; R Rubio; R M Berne
Journal:  J Mol Cell Cardiol       Date:  1975-06       Impact factor: 5.000

2.  Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498.

Authors:  W H van Gilst; P A de Graeff; H Wesseling; C D de Langen
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.105

3.  Release of adenosine in reactive hyperemia of the dog heart.

Authors:  R Rubio; R M Berne; M Katori
Journal:  Am J Physiol       Date:  1969-01

4.  Reperfusion-induced arrhythmias: mechanisms and prevention.

Authors:  A S Manning; D J Hearse
Journal:  J Mol Cell Cardiol       Date:  1984-06       Impact factor: 5.000

5.  Relation of enzyme release and ATP content in digoxin-intoxicated guinea-pig hearts.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1982 Jul-Aug       Impact factor: 17.165

Review 6.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

7.  Antiarrhythmic actions of adenosine in the early stages of experimental myocardial ischaemia.

Authors:  O Fagbemi; J R Parratt
Journal:  Eur J Pharmacol       Date:  1984-04-20       Impact factor: 4.432

8.  Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion.

Authors:  W H Van Gilst; P A De Graeff; J H Kingma; H Wesseling; C D De Langen
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

9.  Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart.

Authors:  J W De Jong; E Harmsen; P P De Tombe; E Keijzer
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

10.  Calcium-dependent atrial slow action potentials generated with phosphatidic acid or phospholipase D.

Authors:  M T Knabb; R Rubio; R M Berne
Journal:  Pflugers Arch       Date:  1984-08       Impact factor: 3.657

View more
  2 in total

1.  Release of adenine nucleotide metabolites by toxic concentrations of cardiac glycosides.

Authors:  W Bernauer
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

2.  Effect of exogenous adenosine deaminase on arrhythmias and the release of adenine nucleotide catabolites in isolated rat hearts with coronary occlusion and reperfusion.

Authors:  W Bernauer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.